• Skip to Content
  • Skip to Sidebar
IU

Indiana University Bloomington Indiana University Bloomington IU Bloomington

Menu

ScIUConversations in Science at Indiana University

  • Home
  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
  • Search

Inching toward a cure for PTSD

Posted on April 3, 2018 by Rachel Skipper

A black and white photo of a woman covering her face with her hands
Image credit: Jose Navarro

Dr. Yvonne Lai is well known for her work at IU’s Gill Center for Biomolecular Science. However, she and her collaborators are also making waves in the business world with the growth of their startup company Anagin Inc., a promising pharmaceutical venture located in Indianapolis.

Dr. Lai’s research focuses on novel drug therapies for post-traumatic stress disorder (PTSD), which is a common neurological disorder that affects seven to eight percent of the population. Available treatments come with a disturbing list of side effects and do not target the disorder’s underlying neural mechanisms. Tackling this problem has been a long journey for Dr. Lai. Now, with the help of a new grant, solutions seem closer.

Prior to her arrival at IU, Dr. Lai developed a compound that works differently from earlier medications. The earlier medications targeted the glutamate receptor, which is located at the surface of neurons, and blocked the normal as well as pathological glutamate signaling. Rather than blocking glutamate signaling at the receptor, Dr. Lai’s compound appears to inhibit the cascade of events that occur after glutamate binds to the receptor. Thus, the compound prevents detrimental changes in the brain’s neurons while also bypassing the severe side effects that arise when all glutamate receptor signaling is blocked.

Soon after her arrival at IU, Dr. Lai collaborated with Psychological and Brain Sciences professor Andrea Hohmann to explore the compound’s effectiveness in a rodent model of chronic pain. She then teamed up with IU School of Medicine Associate Dean and Distinguished Professor Anantha Shekhar to test the compound’s effectiveness in a rodent model of PTSD. They found that the compound was effective in rodents, which motivated them to found Anagin, a small start-up company that focuses on novel PTSD treatments.

In 2014, Dr. Lai and her colleagues were among a select group of scientists to receive an Small Business Innovation Research (SBIR) Grant from the National Institutes of Health. With this funding, they tested a large number of alternatives to Dr. Lai’s original prototype compound, and successfully identified a set of compounds that reduced PTSD-like symptoms in rodents without eliciting severe side effects.

Since then, Anagin has continued to grow. Additional scientists and entrepreneurs have joined the company, including Dr. Jaswant Gidda as the CEO, Jim Schulz as the COO and CFO, and an outstanding Board of Directors, thereby establishing Anagin as an independently-run business. Now, a second SBIR grant for $3 million, funded by the National Institute of Mental Health, places them closer to their goal of developing a new drug to treat PTSD. The team will design improved versions of their compounds that can be taken orally.

Dr. Lai and her colleagues at Anagin hope to find a candidate compound that qualifies for testing in human patients. If the compound successfully makes it through clinical trials and into the market, it would be the first drug of its kind to safely target an underlying mechanism of PTSD. This candidate drug could one day transform the lives of millions of PTSD patients.

To read more about the PTSD drug and startup development process, check out this article written by Liz Rosdeitcher, a science writer in IU’s Department of Psychological and Brain Sciences.

Edited by Kerri Donohue and Victoria Kohout

I would additionally like to acknowledge Liz Rosdeitcher, Dr. Yvonne Lai, and Dr. Lai’s colleagues at Anagin, and thank them for their assistance in editing this article.

Print Friendly, PDF & Email

Related

Filed under: Current Events, Cutting-Edge Science at IU, Spotlight on PeopleTagged brain, Chemistry, experimental psychology, Mental Health, methods, neuroscience, psychology

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Search ScIU

Categories

Tag cloud

#Education #scicomm animal behavior anthropology archaeology astronomy astrophysics Biology biotechnology Black History Month brain cannabinoids cannabis Chemistry climate change conservation coronavirus COVID–19 Diversity in Science diversity in STEM Ecology environment evolution geology history and philosophy of science infectious disease Interdisciplinary Interview Mental Health methods microbiology neuroscience outreach physics Plants primates psychology Research science communication science education Science Outreach science policy Statistics STEM women in STEM

Subscribe

Receive a weekly email with our new content! We will not share or use your information for any other purposes, and you may opt out at any time.

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Current Contributors

  • Log in
  • SPLAT
  • ScIU Guides

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
College of Arts + Sciences

Are you a graduate student at IUB? Would you like to write for ScIU? Email sciucomm@iu.edu


Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Loading Comments...